FDA Inspection 1223277 — Apex360, LLC
The FDA completed an inspection of Apex360, LLC on November 15, 2023 in Burlington, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 15, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Burlington, KY (United States)